Super-enhancer lncs to cardiovascular development and disease

Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1953-60. doi: 10.1016/j.bbamcr.2015.11.026. Epub 2015 Nov 24.

Abstract

Cardiac development, function and pathological remodelling in response to stress depend on the dynamic control of tissue specific gene expression by distant acting transcriptional enhancers. Recently, super-enhancers (SEs), also known as stretch or large enhancer clusters, are emerging as sentinel regulators within the gene regulatory networks that underpin cellular functions. It is becoming increasingly evident that long noncoding RNAs (lncRNAs) associated with these sequences play fundamental roles for enhancer activity and the regulation of the gene programs hardwired by them. Here, we review this emerging landscape, focusing on the roles of SEs and their derived lncRNAs in cardiovascular development and disease. We propose that exploration of this genomic landscape could provide novel therapeutic targets and approaches for the amelioration of cardiovascular disease. Ultimately we envisage a future of ncRNA therapeutics targeting the SE landscape to alleviate cardiovascular disease. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.

Keywords: Enhancers; Heart development; Heart failure; Long noncoding RNAs (lncRNA); Super-enhancers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular System* / embryology
  • Cardiovascular System* / metabolism
  • Cardiovascular System* / physiopathology
  • Enhancer Elements, Genetic*
  • Gene Expression Regulation, Developmental
  • Genetic Predisposition to Disease
  • Genomics / methods
  • Humans
  • Morphogenesis
  • Phenotype
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism
  • Risk Factors

Substances

  • RNA, Long Noncoding